Updated June 27, 2015: The NOAA (National Oceanic and Atmospheric Administration) retracted its earlier announcement and admitted that the warming of the Pacific is NOT caused by El Nino but they kept it quiet. I suppose if they broadcast it, someone might ask the embarrassing question that if it’s not El Nino then what, in fact, is causing the warming of the Pacific?
The Pacific Ocean is dying. I’ve been warning about the Fukushima Dai-ichi nuclear disaster for four years and now its deadly consequences are more apparent every day.
Fukushima’s weapons-grade radioactive aerial fall-out and contaminated ocean currents are bioaccumulating in phytoplankton; the bottom (beginning) of the food chain. As well, it weakens the Pacific marine life’s immune systems making them more susceptible to bacterial, viral and parasitic infestation leading to death and ultimately species extinction…
Federal officials announced they were funding the development of five drugs designed to protect people from the horrors of radiation poisoning. The government’s also financing studies to develop an improved version of another drug to treat people exposed to radioactive particles that could be released during a so-called dirty bomb attack.
Biomedical Advanced Research and Development Authority, or BARDA, a division of the Department of Health and Human Services, announced the roughly $60 million in funding in a series of releases Wednesday and Thursday.
About $56.3 million will go toward five contracts for a variety of drug companies and scientists working on countermeasures for acute radiation syndrome, or radiation sickness. When exposed to high doses of ionizing radiation — such as from a nuclear bomb blast — fast-reproducing cells in the gut, bone marrow, and lungs can be destroyed, which can in turn lead to internal bleeding, a depressed immune system and death over the following days or even weeks.
Winners of contracts include Neumedicines Inc., which got a $17 million award to study recombinant human interleukin-12 (rhuIL-12). Also called HemaMax, a 2008 BARDA-funded study showed it might be able to protect bone marrow from radiation.